ACE2 and viral infectious disease: SARS-CoV [5], HCoV-NL63 [6], and SARS-CoV-2 [7] use angiotensin-converting enzyme 2 (ACE2) as the primary receptor for the binding of the viral transmembrane spike (S) glycoprotein for cell entry, an essential step in establishing viral infection.